The abstract is read at the publisher; the summary is JClub's.
A community-based CABU-EICO bundle in Nanoro, Burkina Faso, and Kimpese, DR Congo reduced Watch-group antibiotic use, with an adjusted prevalence ratio of 0·33.
- Why it matters: Watch-group antibiotic use is increasing in sub-Saharan Africa and may contribute to antimicrobial resistance. The trial addresses whether a community co-created approach can improve antibiotic use without harming patient management.
- What they did: In a cluster-randomised controlled trial, villages/neighbourhoods were assigned 1:1 to intervention or control and received three rounds over 9 months. The intervention combined community education with provider sessions and feedback, using WHO AWaRe Antibiotic Book guidance, and measured outcomes via repeated patient surveys (100 per provider per village) and simulated patient visits.
- The result: Watch-group antibiotic use fell from 26·8% to 17·1% in the intervention group and rose from 13·4% to 21·2% in controls, yielding an adjusted prevalence ratio of 0·33 (95% CI 0·14–0·78). Patient management score changes were minimal, implying no negative effect on management.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.